Development of a whole-cell assay for peptidoglycan biosynthesis inhibitors

Antimicrobial Agents and Chemotherapy

Volumn 46, Issue 4, 2002, Pages 943-946

  Barbosa, Maria D F S ^a   Yang, Gaoyun ^a   Fang, Jie ^a   Kurilla, Michael G ^a   Pompliano, David L ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; BACITRACIN; BAMBERMYCIN; CARBON 14; CPD 1; CPD 2; CYCLOSERINE; FOSFOMYCIN; PENICILLIN G; PEPTIDOGLYCAN; UNCLASSIFIED DRUG; URIDINE DIPHOSPHATE N ACETYLGLUCOSAMINE; URIDINE DIPHOSPHATE N ACETYLGLUCOSAMINE ENOLPYRUVYL TRANSFERASE; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; BIOSYNTHESIS; CANDIDA ALBICANS; ESCHERICHIA COLI; GENE EXPRESSION; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ALKYL AND ARYL TRANSFERASES; BIOLOGICAL ASSAY; CATALYSIS; CLONING, MOLECULAR; DNA, BACTERIAL; ENZYME INHIBITORS; ESCHERICHIA COLI; INDICATORS AND REAGENTS; MICROBIAL SENSITIVITY TESTS; PEPTIDOGLYCAN; PLASMIDS; URIDINE DIPHOSPHATE N-ACETYLGLUCOSAMINE;

EID: 0036203528     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.46.4.943-946.2002     Document Type: Article

References (22)

1. Susceptibility testing of antimicrobials in liquid medium
2. The lysis protein E of φX174 is a specific inhibitor of the MraY-catalyzed step in peptidoglycan synthesis
3. A protein antibiotic in the phage Qβ virion: Diversity in lysis targets
4. MraY is an essential gene for cell growth in Escherichia coli
5. Assay for identification of inhibitors for bacterial MraY translocase and MurG transferase
6. Nuances of mechanisms and their implications for evolution of the versatile β-lactamase activity: From biosynthetic enzymes to drug resistance factors
7. Novel scintillation proximity assay for measuring membrane-associated steps of peptidoglycan biosynthesis in Escherichia coli
8. Escherichia coli mutants lacking all possible combinations of eight penicillin binding proteins: Viability, characteristics, and implications for peptidoglycan synthesis
9. The discovery of cell wall active antibacterial antibiotics
10. Vancomycin derivatives that inhibit peptidoglycan biosynthesis without binding D-Ala-D-Ala
11. Inhibition of transglycosylation involved in bacterial peptidoglycan synthesis
12. Characterization of a Cys115 to Asp substitution in the Escherichia coli cell wall biosynthetic enzyme UDP-GlcNAc enolpyruvyl transferase (MurA) that confers resistance to inactivation by the antibiotic fosfomycin
13. Substrate and inhibitor-induced conformational changes in the structurally related enzymes UDP-N-acetylglucosamine enolpyruvyl transferase (MurA) and 5-enolpyruvylshikimate 3-phosphate synthase (EPSPS)
14. Cloning and sequencing of Escherichia coli murZ and purification of its product, a UDP-N-acetylglucosamine enolpyruvyl transferase
15. Kinetics, stoichiometry, and identification of the reactive thiolate in the inactivation of UDP-GlcNAc enolpyruvoyl transferase by the antibiotic fosfomycin
16. Surface proteins of gram-positive bacteria and mechanisms of their targeting to the cell wall envelope
17. Signal transduction by a death signal peptide: Uncovering the mechanism of bacterial killing by penicillin
18. Antibiotic susceptibility profiles of Escherichia coli strains lacking multidrug efflux pump genes
19. Multiple antibiotic resistance in a bacterium with suppressed autolytic system
20. Mining bacterial cell wall biosynthesis with new tools: Multitarget screens
21. Engineering a cell-free murein biosynthetic pathway: Combinatorial enzymology in drug discovery
22. Pyruvate-uridine diphospho-N-acetylglucosamine transferase. Purification to homogeneity and feedback inhibition